The signed contract includes the joint use of innovative technologies for the identification and production of novel enzymes from aquatic sources,amongst others. “Dormant potentials of marine habitats for biotransformations can be deciphered and brought into market by the focused application of proteomics-based biotechnology”, says Prof. Dr. Thomas Schweder of the IMaB. ”Together with Enzymicals AG, we can offer our expertise in the field of de novo genome sequencing and gene annotation to a wide audience as a service.”
Thewhole value chain can be covered jointly by merchandising of new biocatalysts from aquatic systems and the application-oriented process development by Enzymicals AG.
The two institutionscomplement each other in their strategic alignment perfectly by the construction of expression systems and production strains for applications in fine chemistry.
“Thus, our customers will gain access to exquisite biocatalysts for applications in the chemical and pharmaceutical industry”, adds Dr. Ulf Menyes, CEO of Enzymicals AG, who foresees a strengthening of core competencies by the partnership.
Both new and existing customers will gain a long-term competitive advantage in tailored product and process development based on innovative biocatalysts from the cooperation of both institutions.About Enzymicals AG:
The interdisciplinary team of biochemists, biologists, synthetic and process chemists is led by Dr. Ulf Menyes (chemist) as chief executive officer (CEO) and Dr. Rainer Wardenga (biologist) as head of research and production (CSO). The Enzymicals AG has establishedcollaborations with leading companies in the chemical industry and established the technical requirements for the production of enzymes and for the biotechnological synthesis of specialty and fine chemicals on kg-scalewithin a short period of time. Enzymicals is member of BioCon Valley MV e.V.About the Institute of Marine Biotechnologye.V.:
A particular focus is on the field of functional genomics of marine microorganisms. The increasing number of sequenced genomes of marine bacteria and the extensive data on marine metagenomes allow a comprehensive insight into the previously unknown metabolic activities of marine organisms. The functional genome analysis is substantially supported by the analysis of the physiological proteome. One of the most modern and best equipped proteome centers in Germany was established at the University of Greifswald in recent years. These technologies are used by the IMaB to determine relevant, new gene functions and to make them accessible for biotechnological applications. The Institute is member of BioCon Valley MV e.V.Contact:
Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery
20.01.2017 | GSI Helmholtzzentrum für Schwerionenforschung GmbH
Seeking structure with metagenome sequences
20.01.2017 | DOE/Joint Genome Institute
An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...
Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...
Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.
While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...
Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales
Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...
Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.
As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...
19.01.2017 | Event News
10.01.2017 | Event News
09.01.2017 | Event News
20.01.2017 | Awards Funding
20.01.2017 | Materials Sciences
20.01.2017 | Life Sciences